跳至主要内容
临床试验/NCT04231591
NCT04231591已完成不适用

NT-proBNP Levels in the Prediction of Intrapartum and Postpartum Events in Adult Congenital Heart Disease Patients

Mayo Clinic1 个研究点 分布在 1 个国家目标入组 34 人开始时间: 2019年11月13日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
Mayo Clinic
入组人数
34
试验地点
1
主要终点
Postpartum cardiac complications

研究概览

简要总结

The purpose of this study is to determine if NT-BNP levels obtained at time of admission for delivery are predictive of intrapartum or postpartum complications in patients with adult congenital heart disease.

详细描述

Amino-terminal pro-B-type natiuretic peptide (NT-proBNP) is a prohormone released from cardiac ventricular myocytes in direct response to cardiac workload. Secreted in the biologically inactive form, NT-proBNP is cleaved in the circulation into BNP, which subsequently exerts both vasodilatory and diuretic effects. The principal clinical utility of serum NT-proBNP measurement has been as an adjunctive marker in the diagnosis of subclinical heart failure, with higher levels typically reflective of increasing cardiac dysfunction.

The proposed prospective cohort study intends to collect serum NT-proBNP levels in singleton ACHD patients and a comparative normotensive control group at time of admission for delivery to characterize negative predictive values for intrapartum and postpartum cardiac events. Both pregnant patients with previously-diagnosed ACHD and those diagnosed and delivering during the study interval will be candidates for participation, and a gestational age threshold of 37 weeks will be utilized for the control group.

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Prospective

入排标准

年龄范围
18 Years 至 50 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • Pregnant adult women ages 18 - 50
  • Pregnancy with congenital heart disease (study group) or without congenital heart disease (control group)

排除标准

  • Non-pregnant patients
  • Non-English-speaking patients
  • Maternal age <18 years or >50 years
  • Patients with hypertensive complications of pregnancy
  • Maternal peripartum cardiomyopathy
  • Multiple gestation

结局指标

主要结局

Postpartum cardiac complications

时间窗: Initial 96 hours following delivery of infant(s)

Incidence of heart failure, incidence of arrhythmia, incidence of cardiac arrest

Intrapartum cardiac complications

时间窗: Inpatient admission for subsequent 48 hours

Incidence of heart failure, incidence of arrhythmia, incidence of cardiac arrest

次要结局

  • Intrapartum obstetrical complications(Inpatient admission for subsequent 48 hours)
  • Postpartum obstetrical complications(Initial 96 hours following delivery of infant(s))

研究者

发起方
Mayo Clinic
申办方类型
Other
责任方
Principal Investigator
主要研究者

Carl H. Rose

Principal Investigator

Mayo Clinic

研究点 (1)

Loading locations...

相似试验

NT-proBNP Levels in the Prediction of Intrapartum... | 临床试验